Project description
Laser treatment for glaucoma
Glaucoma is an eye disease caused by damage to the optic nerve and unless treated, it can cause vision loss. Funded by the European Innovation Council, the EyeAccess project is introducing a novel laser treatment for glaucoma. The Eagle™ device is automated, easy to use and can be operated by non-expert personnel, making it accessible to more doctors as a first-line treatment for glaucoma patients. Moreover, the Eagle device, which is CE marked, is a patient-friendly, simple and non-contact procedure which will guarantee patient compliance and expedited application in more patients.
Objective
Our novel laser technology - Direct Selective Laser Trabeculoplasty (DSLT) is an automated laser procedure for accessible primary treatment of glaucoma and ocular hypertension. Our Eagle device has the potential to revolutionize glaucoma care as it is non-contact, intuitive, and quick.
The technology is ground-breaking, as the procedure doesnt require expertise and involves simply pressing a button and delivering treatment in seconds. DSLT technology is poised to achieve widespread acceptance, as it is not limited to glaucoma specialists, or bound to glaucoma medication
compliance. In addition, our technology is supported by promising First-in-Human clinical trial results as well as the expertise and guidance of key opinion leaders in the field of ophthalmology. EIC funding will support BELKIN Laser (re-branded recently as BELKIN Vision) in commercializing
this sight-saving technology by establishing the commercial value chain, market launch, and scale-up.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine ophthalmology glaucoma
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.3.1 - The European Innovation Council (EIC)
MAIN PROGRAMME
See all projects funded under this programme -
HORIZON.3.1.2 - The Accelerator
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-EIC-2021-ACCELERATOROPEN-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
8122214 Yavne
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.